Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD
Summary: Protein post-translational modifications (PTMs) participate in important bioactive regulatory processes and therefore can help elucidate the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Here, we investigate the involvement of PTMs in ketogenic diet (KD)-improved fatty liver by...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-04-01
|
| Series: | Cell Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124723003303 |
| _version_ | 1797854322358222848 |
|---|---|
| author | Huanyi Cao Qingxian Cai Wanrong Guo Qiao Su Hancheng Qin Tian Wang Yingxin Xian Longyi Zeng Mengyin Cai Haixia Guan Sifan Chen Hua Liang Fen Xu |
| author_facet | Huanyi Cao Qingxian Cai Wanrong Guo Qiao Su Hancheng Qin Tian Wang Yingxin Xian Longyi Zeng Mengyin Cai Haixia Guan Sifan Chen Hua Liang Fen Xu |
| author_sort | Huanyi Cao |
| collection | DOAJ |
| description | Summary: Protein post-translational modifications (PTMs) participate in important bioactive regulatory processes and therefore can help elucidate the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Here, we investigate the involvement of PTMs in ketogenic diet (KD)-improved fatty liver by multi-omics and reveal a core target of lysine malonylation, acetyl-coenzyme A (CoA) carboxylase 1 (ACC1). ACC1 protein levels and Lys1523 malonylation are significantly decreased by KD. A malonylation-mimic mutant of ACC1 increases its enzyme activity and stability to promote hepatic steatosis, whereas the malonylation-null mutant upregulates the ubiquitination degradation of ACC1. A customized Lys1523ACC1 malonylation antibody confirms the increased malonylation of ACC1 in the NAFLD samples. Overall, the lysine malonylation of ACC1 is attenuated by KD in NAFLD and plays an important role in promoting hepatic steatosis. Malonylation is critical for ACC1 activity and stability, highlighting the anti-malonylation effect of ACC1 as a potential strategy for treating NAFLD. |
| first_indexed | 2024-04-09T20:04:06Z |
| format | Article |
| id | doaj.art-455c0e4668144867ae89719ff16b07d9 |
| institution | Directory Open Access Journal |
| issn | 2211-1247 |
| language | English |
| last_indexed | 2024-04-09T20:04:06Z |
| publishDate | 2023-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Cell Reports |
| spelling | doaj.art-455c0e4668144867ae89719ff16b07d92023-04-02T06:12:51ZengElsevierCell Reports2211-12472023-04-01424112319Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLDHuanyi Cao0Qingxian Cai1Wanrong Guo2Qiao Su3Hancheng Qin4Tian Wang5Yingxin Xian6Longyi Zeng7Mengyin Cai8Haixia Guan9Sifan Chen10Hua Liang11Fen Xu12Department of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, P.R. China; Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, P.R. China; Department of Endocrinology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, P.R. ChinaDepartment of Hepatopathy, the Third People’s Hospital of Shenzhen, the Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518112, P.R. ChinaDepartment of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, P.R. China; Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, P.R. ChinaAnimal Experiment Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, P.R. ChinaDepartment of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, P.R. China; Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, P.R. ChinaDepartment of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, P.R. China; Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, P.R. ChinaDepartment of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, P.R. China; Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, P.R. ChinaDepartment of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, P.R. China; Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, P.R. ChinaDepartment of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, P.R. China; Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, P.R. ChinaDepartment of Endocrinology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, P.R. ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, P.R. China; Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, P.R. ChinaDepartment of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, P.R. China; Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, P.R. China; Corresponding authorDepartment of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, P.R. China; Guangdong Provincial Key Laboratory of Diabetology, Guangzhou 510630, P.R. China; Corresponding authorSummary: Protein post-translational modifications (PTMs) participate in important bioactive regulatory processes and therefore can help elucidate the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Here, we investigate the involvement of PTMs in ketogenic diet (KD)-improved fatty liver by multi-omics and reveal a core target of lysine malonylation, acetyl-coenzyme A (CoA) carboxylase 1 (ACC1). ACC1 protein levels and Lys1523 malonylation are significantly decreased by KD. A malonylation-mimic mutant of ACC1 increases its enzyme activity and stability to promote hepatic steatosis, whereas the malonylation-null mutant upregulates the ubiquitination degradation of ACC1. A customized Lys1523ACC1 malonylation antibody confirms the increased malonylation of ACC1 in the NAFLD samples. Overall, the lysine malonylation of ACC1 is attenuated by KD in NAFLD and plays an important role in promoting hepatic steatosis. Malonylation is critical for ACC1 activity and stability, highlighting the anti-malonylation effect of ACC1 as a potential strategy for treating NAFLD.http://www.sciencedirect.com/science/article/pii/S2211124723003303CP: Metabolism |
| spellingShingle | Huanyi Cao Qingxian Cai Wanrong Guo Qiao Su Hancheng Qin Tian Wang Yingxin Xian Longyi Zeng Mengyin Cai Haixia Guan Sifan Chen Hua Liang Fen Xu Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD Cell Reports CP: Metabolism |
| title | Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD |
| title_full | Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD |
| title_fullStr | Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD |
| title_full_unstemmed | Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD |
| title_short | Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD |
| title_sort | malonylation of acetyl coa carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in nafld |
| topic | CP: Metabolism |
| url | http://www.sciencedirect.com/science/article/pii/S2211124723003303 |
| work_keys_str_mv | AT huanyicao malonylationofacetylcoacarboxylase1promoteshepaticsteatosisandisattenuatedbyketogenicdietinnafld AT qingxiancai malonylationofacetylcoacarboxylase1promoteshepaticsteatosisandisattenuatedbyketogenicdietinnafld AT wanrongguo malonylationofacetylcoacarboxylase1promoteshepaticsteatosisandisattenuatedbyketogenicdietinnafld AT qiaosu malonylationofacetylcoacarboxylase1promoteshepaticsteatosisandisattenuatedbyketogenicdietinnafld AT hanchengqin malonylationofacetylcoacarboxylase1promoteshepaticsteatosisandisattenuatedbyketogenicdietinnafld AT tianwang malonylationofacetylcoacarboxylase1promoteshepaticsteatosisandisattenuatedbyketogenicdietinnafld AT yingxinxian malonylationofacetylcoacarboxylase1promoteshepaticsteatosisandisattenuatedbyketogenicdietinnafld AT longyizeng malonylationofacetylcoacarboxylase1promoteshepaticsteatosisandisattenuatedbyketogenicdietinnafld AT mengyincai malonylationofacetylcoacarboxylase1promoteshepaticsteatosisandisattenuatedbyketogenicdietinnafld AT haixiaguan malonylationofacetylcoacarboxylase1promoteshepaticsteatosisandisattenuatedbyketogenicdietinnafld AT sifanchen malonylationofacetylcoacarboxylase1promoteshepaticsteatosisandisattenuatedbyketogenicdietinnafld AT hualiang malonylationofacetylcoacarboxylase1promoteshepaticsteatosisandisattenuatedbyketogenicdietinnafld AT fenxu malonylationofacetylcoacarboxylase1promoteshepaticsteatosisandisattenuatedbyketogenicdietinnafld |